Doxorubicin has been in clinical use for breast cancer since the 1970s. Despite decades of newer drug development, NCCN, ASCO and ESMO guidelines continue to list anthracycline-based regimens — including AC and EC — among the standard options for eligible patients with early and locally advanced breast cancer.
AC and EC: — The Anthracycline Backbone Explained
Your chart shows an acronym. Here is what each letter stands for, why two different regimens share the same structure, and what you can expect from treatment.
- Two drugs, one backbone — Both AC and EC pair an anthracycline — doxorubicin or epirubicin — with cyclophosphamide.
- The letters are the drug initials — A is Adriamycin (doxorubicin). E is epirubicin. C is cyclophosphamide. EC and AC differ by one drug.
- Given in repeated cycles — Both regimens are given in a series of cycles, with a rest period between each one.
- Heart monitoring is built in — Anthracyclines affect the heart over time, so a heart scan before treatment is standard practice.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
AC is doxorubicin (sold as Adriamycin) combined with cyclophosphamide. EC is the same two-drug structure with epirubicin replacing doxorubicin. Both are anthracycline-based regimens used in breast cancer, typically given across a series of cycles. Which one your team chooses depends on your individual clinical picture, not patient preference.
What happens during an AC or EC treatment cycle?
Baseline assessment
Before your first cycle, your team checks blood counts and organ function. An echocardiogram (heart scan) is done to establish your baseline before anthracycline treatment begins.
Pre-medications on treatment day
You receive anti-nausea medicine through an intravenous line before the chemotherapy. This is routine — given to reduce nausea during and after the infusion.
Chemotherapy infusion
The drugs are given through a cannula or a central venous line. Infusion time varies by protocol. Most patients receive AC or EC as day care and go home the same day.
Observation before discharge
After the infusion, your team observes you before you leave. Any immediate reactions are identified and managed before discharge.
Recovery at home
The days after each cycle are often the most demanding for fatigue and nausea. Your team gives written guidance on managing side effects and which symptoms to report the same day.
Blood test before the next cycle
Your blood count is checked before each cycle. If counts are not in the acceptable range, the next cycle may be delayed. This is a standard safety measure, not a setback.
Tell your oncologist before your first cycle
- Any history of heart disease, heart failure, or irregular heart rhythm
- Prior anthracycline chemotherapy — doxorubicin, epirubicin, or daunorubicin — for any previous cancer
- All current medicines, supplements, and herbal preparations
- Any known kidney or liver problems
- Pregnancy, plans to conceive, or breastfeeding
- Any recent severe infection or current fever
- Regular alcohol use
How does EC differ from AC?
The letters name the drugs: A is Adriamycin, the brand name for doxorubicin. E is epirubicin. C is cyclophosphamide in both regimens.
Doxorubicin and epirubicin belong to the same anthracycline family. Both work by interfering with the enzyme cancer cells need to copy their DNA. They differ in their side-effect profiles, which is one factor that guides the choice between them.
The decision between AC and EC is made by your oncologist based on your specific situation. Neither is universally preferable.
Who is AC or EC chemotherapy not for?
AC and EC are not given to everyone with breast cancer. An oncologist decides eligibility for each patient individually, based on test results and clinical assessment.
These regimens are generally not used in:
- People with significantly reduced heart function, including pre-existing heart failure or a low ejection fraction on echocardiogram.
- People who have already received the maximum cumulative lifetime dose of anthracyclines — whether doxorubicin, epirubicin, or a related drug — for any previous cancer.
- People with severe liver impairment, because both doxorubicin and epirubicin are metabolised by the liver and reach harmful levels when liver function is severely reduced.
- People with active severe infection or very low blood counts at the time a cycle is due.
- During pregnancy, in most circumstances. The risks to the developing foetus are significant, and any use in pregnancy is an exceptional decision made by a specialist team.
What does each letter stand for?
- AC
- Doxorubicin (brand name Adriamycin) plus cyclophosphamide. The A comes from Adriamycin.
- EC
- Epirubicin plus cyclophosphamide. Epirubicin replaces doxorubicin; cyclophosphamide is the same drug as in AC.
- Anthracycline
- The drug class that includes both doxorubicin and epirubicin. Anthracyclines interfere with an enzyme cells need to replicate their DNA.
- Cyclophosphamide
- An alkylating agent — a drug that damages the DNA of rapidly dividing cells. It is the C in both AC and EC.
- Adjuvant
- Chemotherapy given after surgery, to reduce the risk of cancer returning. AC and EC are used in both adjuvant and neoadjuvant settings.
- Neoadjuvant
- Chemotherapy given before surgery, with the aim of reducing tumour size first. Your treatment plan will state which applies to you.
Why is heart monitoring part of anthracycline treatment?
Doxorubicin and epirubicin can affect the heart muscle. This effect accumulates with each dose you receive across your lifetime — not just in the current course of treatment.
Your team tracks the total amount of anthracycline you have ever received, including treatment given years ago for a different cancer. A baseline echocardiogram before starting is standard, and repeat scans may follow during or after your course.
Tell your team promptly if you notice new breathlessness, ankle swelling, palpitations, or unusual fatigue during or after treatment. These are not expected side effects and need assessment.
Did you know?
The longevity of a regimen in international guidelines reflects how extensively it has been studied across many thousands of patients, not an absence of alternatives.
Source: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer; ESMO Early Breast Cancer Clinical Practice Guidelines
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
What is the difference between AC and AC-T?
AC-T adds a taxane — usually paclitaxel or docetaxel — as a second phase after the AC cycles are complete. The T stands for taxane. This page covers AC and EC alone, the anthracycline-and-cyclophosphamide backbone, without a taxane phase. If your chart shows AC-T, AC-TH or a similar extended acronym, ask your oncologist to walk you through the full sequence and explain what each phase is intended to do in your specific case.
Is EC the same as FEC?
No. FEC adds fluorouracil as a third drug to the epirubicin and cyclophosphamide combination — the F stands for fluorouracil. EC is a two-drug regimen; FEC is three drugs. They share two components but are different protocols with different side-effect profiles. If you are unsure whether your regimen is EC or FEC, check your written treatment summary or ask your team directly, because the distinction matters for understanding what to expect.
How many cycles of AC or EC will I have?
The number of cycles is part of your individual treatment plan and is decided by your oncologist. It depends on whether you are having treatment before or after surgery, your tumour biology, and how you tolerate each cycle. Your oncologist will tell you the planned number at the start. That plan can be reviewed if your circumstances change — a delayed cycle or a reduction in dose is a clinical adjustment, not a sign the treatment is failing.
Will I lose my hair on AC or EC?
Hair loss is very common with both regimens, and with doxorubicin in particular it is typically complete. It usually begins within a few weeks of starting treatment. Hair generally regrows after treatment ends, though the initial texture may differ. Ask your team about scalp cooling before your first cycle if you want to explore that option — it is easier to discuss before treatment starts than after.
Can AC or EC be given if I have a heart condition?
That depends entirely on the type and severity of your heart condition and your current heart function as measured by echocardiogram. Significantly reduced heart function is one situation where anthracyclines are generally not used. A mild or well-controlled cardiac history does not automatically rule them out. Your oncologist and, where needed, a cardiologist review this together before any decision is made. Do not assume you are or are not eligible on the basis of a previous diagnosis alone.
Which side effects should I report the same day rather than waiting?
Contact your team the same day if you develop a fever — any temperature that feels high or above what your thermometer shows as normal — because this can indicate a serious infection when your immune system is suppressed. Also report new or worsening breathlessness, chest pain, palpitations, or ankle swelling, as these may indicate a cardiac effect requiring prompt review. Bloody diarrhoea or inability to keep fluids down also need same-day contact. Your team will give you written guidance including the specific thresholds to watch for before your first cycle.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.